Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry.
about
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesEndogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertensionTargeting epoxides for organ damage in hypertensionGenetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhageSoluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single AgentCytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationEpoxides and soluble epoxide hydrolase in cardiovascular physiologyAnalysis of epoxyeicosatrienoic acids by chiral liquid chromatography/electron capture atmospheric pressure chemical ionization mass spectrometry using [13C]-analog internal standards.Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cellsThe rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.Formation of cis-14,15-oxido-5,8,11-icosatrienoic acid from phosphatidylinositol in human platelets.Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in ratsCytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting ductEpoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibitionCardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat modelIncreases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.Overexpression of G-protein-coupled receptor 40 enhances the mitogenic response to epoxyeicosatrienoic acidsThe anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.Eicosanoids and renal damage in cardiometabolic syndrome.The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acidsVascular pharmacology of epoxyeicosatrienoic acidsDual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice.Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemiaAn eicosanoid-centric view of atherothrombotic risk factorsRoles of the epoxygenase CYP2J2 in the endothelium.The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.Epoxyeicosatrienoic acid analogs and vascular function.Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry.Cytochrome P450 eicosanoids in cerebrovascular function and disease.The expansive role of oxylipins on platelet biology.Epoxyeicosatrienoic acid stimulates ADP-ribosylation of a 52 kDa protein in rat liver cytosolAnti-inflammatory ω-3 endocannabinoid epoxides.Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes.
P2860
Q24597172-95B56526-35BB-40B0-93F5-E027FD89C83AQ28331116-3543524F-5667-45FC-981A-F752F249B05AQ28387558-9361CBA4-5EE0-4193-A42D-2A007715D648Q28390328-FF0D43F2-BFEF-4170-8F14-69548D1EBDC6Q28391163-F94C7AFD-5633-43C0-87DC-DDE63AEA6D1FQ28393303-B5D76322-7535-42D9-B40E-3C8F8C211BB8Q28396313-FD301EB4-437D-4332-8F55-A84813A90207Q33448255-CE429A23-A12E-4FB0-A738-60346631DD3CQ34027743-F99E6C0A-51CD-4DCA-8B02-9912B3F18F4EQ34217198-D66F9868-C927-4C60-B604-27659B1E2A7CQ34351500-D6F461F6-0FF6-4B0F-94A1-D309D4611470Q34357126-F7280E58-A8DC-40F4-98E5-4E40CA84A826Q34580785-445137CC-8C36-417F-9BBB-8BB68C6A2CFCQ34586571-09B44619-7FF0-4742-A806-D810F7F0F511Q35026344-EFF83900-47D4-4206-AD4C-068B8F0C769EQ35056911-BF4842D6-9B32-4CFD-BEB2-546A4E87B364Q35094877-CF08F045-20B2-4574-B9FF-EF995080052BQ35196023-C250D179-FA58-423E-A882-F459D9CA9D1BQ35947602-6D713C25-3EBB-41E0-89CE-EB7F72B1593DQ35984991-C49093C3-E910-40CC-B4A8-9847829F4FFBQ36027183-46508B5E-C458-4914-9017-C386BDFDCEF5Q36545303-74CD6340-E6AF-4907-8AB1-A646E15E16EBQ36625899-2BA1A7D8-02FF-4521-851D-E440CCE4D13CQ36952174-1A8FD084-758A-489D-A5E1-D3C304BC5326Q37014713-14A5680B-9E0C-4F42-B367-9BBC31AF94A0Q37418399-F355C9D3-A761-434A-9CDC-C1C70CBAB247Q37693177-92C10C5E-5207-47E5-9FE2-9C2EBE39157CQ38222606-88F2DC9C-9669-49F3-8FC7-6136296A879CQ39319956-DC354E6D-BA8C-4AEA-AF75-B3FB41B4CA5FQ39320449-707388FA-31AF-4B3A-B81C-9DCAA50850CAQ42161733-0E3D96CC-C74D-4438-BF9E-1D870E8EB7B5Q47948005-E6C8E5DE-B539-440B-B42D-A387B66C80BAQ53927544-878918B5-7EF7-4058-8B4F-68843EC43ECD
P2860
Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@en
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@nl
type
label
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@en
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@nl
prefLabel
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@en
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@nl
P2093
P1476
Inhibition of cyclooxygenase a ...... Influence of stereochemistry.
@en
P2093
F A Fitzpatrick
M A Wynalda
W F Liggett
P304
15334-15338
P407
P577
1986-11-01T00:00:00Z